BSE filing, NSE: MANIPALHOS. Summary written from the filing by ALFA Finder's alert engine.
Manipal Health Enterprises Ltd: key numbers
- Share price
- ₹643.25
- Market cap
- ₹84,612 Cr
- Revenue (annual)
- ₹10,336 Cr
- Net profit (annual)
- ₹892.3 Cr
- Promoter holding
- 72.08%
- FII holding
- 3.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manipal Health Enterprises Ltd
All →Manipal Health Enterprises Other Announcement
This is a quarterly shareholding pattern filing for Manipal Health Enterprises Ltd for the quarter ended September 30, 2026, pursuant to Regulation 31(1)(b).
Manipal Health Enterprises Annual General Meeting
Manipal Health Enterprises held its 16th AGM on September 29, 2026. Shareholders considered and approved various ordinary and special business items, including director appointments and ESOPs.
Manipal Health Enterprises Share Pledge
Manipal Health Enterprises disclosed a Reg 31(1) encumbrance over 17.43% of promoter shares. The pledge secures up to Rs 500 Crore of Claypond NCDs.
- Value
- ₹500.0 Cr
Manipal Health Enterprises Debt & Borrowing: ₹5,310 Cr
Manipal Health Enterprises Ltd has utilized IPO proceeds for the full redemption of its subsidiary's outstanding listed non-convertible debentures. The total nominal value redeemed is Rs. 5,310 Crore.
- Value
- ₹5,310 Cr
Manipal Health Enterprises Annual General Meeting
Manipal Health Enterprises issued a notice for its 16th Annual General Meeting scheduled for September 29, 2026, to transact ordinary and special business.
Manipal Health Enterprises Share Pledge
Promoters of Manipal Health Enterprises Limited created an encumbrance on 23,21,47,755 shares, representing 17.43% stake. This pertains to covenants under financing documents for NCDs worth Rs.500 Crore.
- Value
- ₹500.0 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.